The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Non-LVP Parenterals Products Market Research Report 2025
Synopsis
Non-LVP parenterals products referred to the small volume parenteral except biologicals. Small volume parenteral solutions are usually 100 ml or less and are packaged in different ways depending on the intended use. If the SVP is a liquid that is used primarily to deliver medications, it is packaged in a small plastic bag called a minibag of 50 - 100 ml (minibags look like small plastic LVP bags). SVPs can also be packaged as ampules, vials, and prefilled syringes. Liquid drugs are supplied in prefilled syringes, heat-sealed ampules, or in vials sealed with a rubber closure. Powdered drugs are supplied in vials and must be constituted (dissolved in a suitable liquid) before being added to any solution. SVPs packaged as ampules, vials, or prefilled syringes are typically added to a minibag or a LVP but they may also serve as the final container. The term admixture is used to denote a solution where such an additive has been added to a minibag or LVP.
The global Non-LVP Parenterals Products market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Non-LVP Parenterals Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Non-LVP Parenterals Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Non-LVP Parenterals Products include Allergan, Bayer, GSK, J&J, Pfizer, Teva and Novartis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Non-LVP Parenterals Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-LVP Parenterals Products.
Report Scope
The Non-LVP Parenterals Products market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-LVP Parenterals Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-LVP Parenterals Products manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Bayer
GSK
J&J
Pfizer
Teva
Novartis
Segment by Type
Ampules
Vials
Prefilled Syringes
Segment by Application
Local Anesthetics
Vaccines
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-LVP Parenterals Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-LVP Parenterals Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Non-LVP parenterals products referred to the small volume parenteral except biologicals. Small volume parenteral solutions are usually 100 ml or less and are packaged in different ways depending on the intended use. If the SVP is a liquid that is used primarily to deliver medications, it is packaged in a small plastic bag called a minibag of 50 - 100 ml (minibags look like small plastic LVP bags). SVPs can also be packaged as ampules, vials, and prefilled syringes. Liquid drugs are supplied in prefilled syringes, heat-sealed ampules, or in vials sealed with a rubber closure. Powdered drugs are supplied in vials and must be constituted (dissolved in a suitable liquid) before being added to any solution. SVPs packaged as ampules, vials, or prefilled syringes are typically added to a minibag or a LVP but they may also serve as the final container. The term admixture is used to denote a solution where such an additive has been added to a minibag or LVP.
The global Non-LVP Parenterals Products market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Non-LVP Parenterals Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Non-LVP Parenterals Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Non-LVP Parenterals Products include Allergan, Bayer, GSK, J&J, Pfizer, Teva and Novartis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Non-LVP Parenterals Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-LVP Parenterals Products.
Report Scope
The Non-LVP Parenterals Products market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-LVP Parenterals Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-LVP Parenterals Products manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Bayer
GSK
J&J
Pfizer
Teva
Novartis
Segment by Type
Ampules
Vials
Prefilled Syringes
Segment by Application
Local Anesthetics
Vaccines
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-LVP Parenterals Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-LVP Parenterals Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Non-LVP Parenterals Products Market Overview
1.1 Product Overview and Scope of Non-LVP Parenterals Products
1.2 Non-LVP Parenterals Products Segment by Type
1.2.1 Global Non-LVP Parenterals Products Market Value Comparison by Type (2024-2030)
1.2.2 Ampules
1.2.3 Vials
1.2.4 Prefilled Syringes
1.3 Non-LVP Parenterals Products Segment by Application
1.3.1 Global Non-LVP Parenterals Products Market Value by Application: (2024-2030)
1.3.2 Local Anesthetics
1.3.3 Vaccines
1.3.4 Other
1.4 Global Non-LVP Parenterals Products Market Size Estimates and Forecasts
1.4.1 Global Non-LVP Parenterals Products Revenue 2019-2030
1.4.2 Global Non-LVP Parenterals Products Sales 2019-2030
1.4.3 Global Non-LVP Parenterals Products Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Non-LVP Parenterals Products Market Competition by Manufacturers
2.1 Global Non-LVP Parenterals Products Sales Market Share by Manufacturers (2019-2024)
2.2 Global Non-LVP Parenterals Products Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Non-LVP Parenterals Products Average Price by Manufacturers (2019-2024)
2.4 Global Non-LVP Parenterals Products Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-LVP Parenterals Products, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-LVP Parenterals Products, Product Type & Application
2.7 Non-LVP Parenterals Products Market Competitive Situation and Trends
2.7.1 Non-LVP Parenterals Products Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-LVP Parenterals Products Players Market Share by Revenue
2.7.3 Global Non-LVP Parenterals Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-LVP Parenterals Products Retrospective Market Scenario by Region
3.1 Global Non-LVP Parenterals Products Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Non-LVP Parenterals Products Global Non-LVP Parenterals Products Sales by Region: 2019-2030
3.2.1 Global Non-LVP Parenterals Products Sales by Region: 2019-2024
3.2.2 Global Non-LVP Parenterals Products Sales by Region: 2025-2030
3.3 Global Non-LVP Parenterals Products Global Non-LVP Parenterals Products Revenue by Region: 2019-2030
3.3.1 Global Non-LVP Parenterals Products Revenue by Region: 2019-2024
3.3.2 Global Non-LVP Parenterals Products Revenue by Region: 2025-2030
3.4 North America Non-LVP Parenterals Products Market Facts & Figures by Country
3.4.1 North America Non-LVP Parenterals Products Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Non-LVP Parenterals Products Sales by Country (2019-2030)
3.4.3 North America Non-LVP Parenterals Products Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Non-LVP Parenterals Products Market Facts & Figures by Country
3.5.1 Europe Non-LVP Parenterals Products Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Non-LVP Parenterals Products Sales by Country (2019-2030)
3.5.3 Europe Non-LVP Parenterals Products Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-LVP Parenterals Products Market Facts & Figures by Country
3.6.1 Asia Pacific Non-LVP Parenterals Products Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Non-LVP Parenterals Products Sales by Country (2019-2030)
3.6.3 Asia Pacific Non-LVP Parenterals Products Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Non-LVP Parenterals Products Market Facts & Figures by Country
3.7.1 Latin America Non-LVP Parenterals Products Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Non-LVP Parenterals Products Sales by Country (2019-2030)
3.7.3 Latin America Non-LVP Parenterals Products Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-LVP Parenterals Products Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-LVP Parenterals Products Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Non-LVP Parenterals Products Sales by Country (2019-2030)
3.8.3 Middle East and Africa Non-LVP Parenterals Products Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Non-LVP Parenterals Products Sales by Type (2019-2030)
4.1.1 Global Non-LVP Parenterals Products Sales by Type (2019-2024)
4.1.2 Global Non-LVP Parenterals Products Sales by Type (2025-2030)
4.1.3 Global Non-LVP Parenterals Products Sales Market Share by Type (2019-2030)
4.2 Global Non-LVP Parenterals Products Revenue by Type (2019-2030)
4.2.1 Global Non-LVP Parenterals Products Revenue by Type (2019-2024)
4.2.2 Global Non-LVP Parenterals Products Revenue by Type (2025-2030)
4.2.3 Global Non-LVP Parenterals Products Revenue Market Share by Type (2019-2030)
4.3 Global Non-LVP Parenterals Products Price by Type (2019-2030)
5 Segment by Application
5.1 Global Non-LVP Parenterals Products Sales by Application (2019-2030)
5.1.1 Global Non-LVP Parenterals Products Sales by Application (2019-2024)
5.1.2 Global Non-LVP Parenterals Products Sales by Application (2025-2030)
5.1.3 Global Non-LVP Parenterals Products Sales Market Share by Application (2019-2030)
5.2 Global Non-LVP Parenterals Products Revenue by Application (2019-2030)
5.2.1 Global Non-LVP Parenterals Products Revenue by Application (2019-2024)
5.2.2 Global Non-LVP Parenterals Products Revenue by Application (2025-2030)
5.2.3 Global Non-LVP Parenterals Products Revenue Market Share by Application (2019-2030)
5.3 Global Non-LVP Parenterals Products Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Non-LVP Parenterals Products Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Allergan Non-LVP Parenterals Products Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Non-LVP Parenterals Products Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Non-LVP Parenterals Products Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Non-LVP Parenterals Products Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GSK Non-LVP Parenterals Products Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 J&J
6.4.1 J&J Corporation Information
6.4.2 J&J Description and Business Overview
6.4.3 J&J Non-LVP Parenterals Products Sales, Revenue and Gross Margin (2019-2024)
6.4.4 J&J Non-LVP Parenterals Products Product Portfolio
6.4.5 J&J Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Non-LVP Parenterals Products Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Non-LVP Parenterals Products Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Non-LVP Parenterals Products Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Non-LVP Parenterals Products Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Non-LVP Parenterals Products Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Non-LVP Parenterals Products Product Portfolio
6.7.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-LVP Parenterals Products Industry Chain Analysis
7.2 Non-LVP Parenterals Products Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-LVP Parenterals Products Production Mode & Process
7.4 Non-LVP Parenterals Products Sales and Marketing
7.4.1 Non-LVP Parenterals Products Sales Channels
7.4.2 Non-LVP Parenterals Products Distributors
7.5 Non-LVP Parenterals Products Customers
8 Non-LVP Parenterals Products Market Dynamics
8.1 Non-LVP Parenterals Products Industry Trends
8.2 Non-LVP Parenterals Products Market Drivers
8.3 Non-LVP Parenterals Products Market Challenges
8.4 Non-LVP Parenterals Products Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
